CESAR Y CARDONA

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology COLUMBIA, TN NPI 1578728283

General Payments — all program years on this page

$1,435.72

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 53
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $417.67 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $335.4910
Education $82.188

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $210.676
2019 $486.0520
2020 $150.603
2022 $115.773
2023 $54.963
2024 $417.6718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086772799 Novartis Pharmaceuticals Corporation $26.59 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096922414 Novo Nordisk Inc $25.43 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097436711 Novo Nordisk Inc $114.78 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118066971 Boehringer Ingelheim Pharmaceuticals, Inc. $28.32 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118871490 Otsuka America Pharmaceutical, Inc. $21.29 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145828434 AKEBIA THERAPEUTICS INC $27.05 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145831505 AKEBIA THERAPEUTICS INC $26.11 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145833629 AKEBIA THERAPEUTICS INC $24.61 09/25/2024 Education Undisputed 01/23/2026 View at CMS
1146673784 Ardelyx, Inc. $21.63 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149955702 Travere Therapeutics, Inc. $19.85 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149955708 Travere Therapeutics, Inc. $24.44 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149955716 Travere Therapeutics, Inc. $0.37 08/15/2024 Education Undisputed 01/23/2026 View at CMS
1149955722 Travere Therapeutics, Inc. $0.37 08/29/2024 Education Undisputed 01/23/2026 View at CMS
1149955729 Travere Therapeutics, Inc. $3.08 02/20/2024 Education Undisputed 01/23/2026 View at CMS
1149955735 Travere Therapeutics, Inc. $3.08 03/07/2024 Education Undisputed 01/23/2026 View at CMS
1149955740 Travere Therapeutics, Inc. $16.89 08/15/2024 Education Undisputed 01/23/2026 View at CMS
1149955747 Travere Therapeutics, Inc. $16.89 08/29/2024 Education Undisputed 01/23/2026 View at CMS
1149955753 Travere Therapeutics, Inc. $16.89 12/12/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.